FANAPT® SAVINGS CARD

Fanapt® patients can save with each prescription. It’s easy!*
Use your Savings Card and pay as little as $0 copay per month for Fanapt®.

  • Present your Fanapt® prescription and your savings card to your pharmacist every month
card download click
Powered By
Change Healthcare


Get up to 12 months of savings on your prescription.
See below for details.
BIN: 004682
PCN: CN
GRP: EC11601026
ID: 29053573523
Please click here for Important Product Information, including Boxed WARNING.
Eligibility Rules, Terms, and Conditions: Present this card to your pharmacist along with your insurance card and a valid prescription for Fanapt®. Eligible patients may pay as little as $0 copay per month for Fanapt.
Offer valid for up to 12 uses within a calendar year. A valid Prescriber ID# is required on the prescription.
This offer is valid in the United States and Puerto Rico. Offer not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, Tricare or other federal or state health programs (such as medical assistance programs). If the patient is eligible for drug benefits under any such program, the patient cannot use this offer. By using this offer, the patient certifies that he or she will comply with any terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. Patients are not eligible if they are under 18 years of age. It is illegal to (or offer to) sell, purchase, or trade this offer. Program expires 12/31/2017. This offer is not transferable and is limited to one offer per person. Not valid if reproduced. Void where prohibited by law, taxed, or restricted. Program managed by PSKW, LLC on behalf of Vanda Pharmaceuticals. The parties reserve the right to rescind, revoke or amend this offer without notice at any time.
Patient instructions: Present this card, along with your prescription, to a participating pharmacy to save on out-of-pocket expenses for a Fanapt® prescription.

Consumer questions should be directed to 1-844-690-3770.

Pharmacist instructions for a patient with an Eligible Third Party: Submit the claim to the primary Third Party Payer first, then submit the balance due to Change Healthcare as a Secondary Payer COB [coordination of benefits] with patient responsibility amount and a valid Other Coverage Code (e.g., 8). The patient pay amount will be reduced by up to $200 and reimbursement will be received from Change Healthcare.

Pharmacist instructions for a cash-paying patient: Submit this claim to Change Healthcare. A valid Other Coverage Code (e.g., 1) is required. The patient pay amount will be reduced by up to $200 and reimbursement will be received from Change Healthcare.

Valid Other Coverage Code required. For any questions regarding Change Healthcare online processing, please call the Help Desk at 1-800-422-5604.

Fanapt® (iloperidone) tablets: 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg

Please click here for Important Product Information,
including Boxed WARNING.

VANDA and FANAPT are registered trademarks of Vanda Pharmaceuticals Inc. in the United States and other countries.
FANAPT® is licensed by Vanda Pharmaceuticals Inc. from Titan Pharmaceuticals, Inc.

©2017 Vanda Pharmaceuticals Inc. All rights reserved. FAN0071V3 5/17

*Eligibility Rules, Terms, and Conditions:
Present this card to your pharmacist along with your insurance card and a valid prescription for Fanapt®. Eligible patients may pay as little as $0 copay per month for Fanapt. Offer valid for up to 12 uses within a calendar year. A valid Prescriber ID# is required on the prescription.


This offer is valid in the United States and Puerto Rico. Offer not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, Tricare or other federal or state health programs (such as medical assistance programs). If the patient is eligible for drug benefits under any such program, the patient cannot use this offer. By using this offer, the patient certifies that he or she will comply with any terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. Patients are not eligible if they are under 18 years of age. It is illegal to (or offer to) sell, purchase, or trade this offer. Program expires 12/31/2017. This offer is not transferable and is limited to one offer per person. Not valid if reproduced. Void where prohibited by law, taxed, or restricted. Program managed by PSKW, LLC on behalf of Vanda Pharmaceuticals. The parties reserve the right to rescind, revoke or amend this offer without notice at any time.

INDICATION

Fanapt® (iloperidone) tablets are indicated for the treatment of schizophrenia in adults.

Deciding to look at alternate medications is something your doctor may do. Your doctor needs to consider that Fanapt® may change your heart rhythm (meaning there is more time between heartbeats). When taking other drugs that may cause this same change in heart rhythm, you are at a higher risk of a serious, even life-threatening medical issue (torsade de pointes), which may result in sudden death. In many cases, your doctor may prescribe another medication like Fanapt® first.

Fanapt® needs to be taken as directed starting at a low dose and slowly increasing the strength. This may delay the control of symptoms in the first 1 to 2 weeks of treatment. Treatment with Fanapt® for longer than 6 weeks has not been evaluated. Your doctor will evaluate the long-term usefulness of Fanapt® for you.

IMPORTANT SAFETY INFORMATION

BOXED WARNING: Elderly patients with psychosis related to dementia (having lost touch with reality due to memory loss and experiencing a decline in day-to-day functioning) who are treated with antipsychotic medications are at an increased risk of death compared to patients treated with a placebo. Fanapt® is not approved for the treatment of people with dementia-related psychosis.

Patients should not use Fanapt® if they have a known allergy to Fanapt® or its ingredients. Allergic reactions, including anaphylaxis, rapid swelling of the skin (angioedema), and other symptoms of allergy (eg, throat tightness; swelling of the throat, face, lips, mouth and tongue; hives; rash; and itching) have been reported.

An increased risk of stroke (including death) has been reported in clinical studies of elderly people with dementia-related psychosis. Fanapt® is not approved for the treatment of people with dementia-related psychosis.

Fanapt® may change your heart rhythm (mean there is more time between heartbeats). Heart rhythm changes have occurred in patients taking Fanapt® and are a risk factor for serious, even life-threatening medical issues. You should tell your doctor if you have or have had heart problems. Contact your doctor right away if you feel faint or have unpleasant feelings of irregular or forceful heartbeats as any of these feelings could be a sign of a rare, but serious side effect that could be fatal. You should not use Fanapt® with other drugs that are known to cause these same heart rhythm issues.

Tell your doctor if you have some or all of the following symptoms; Very high fever, rigid muscles, shaking, confusion, sweating or increased heart rate and blood pressure. These may be signs of a condition called neuroleptic malignant syndrome (NMS), a rare but serious side effect that could be fatal. This may happen with Fanapt® or drugs like it.

Abnormal or uncontrollable movements of the face, tongue, or other parts of the body may be signs of a serious condition called tardive dyskinesia (TD), which could become permanent. The chance of this condition going away decreases, depending on how long and how much medication has been taken. Tell your doctor if you have body movements you can't control.

Fanapt® and medicines like it have been associated with metabolic changes (high blood sugar, high cholesterol and triglycerides, and weight gain) that can increase cardiovascular/cerebrovascular risks.

Tell your doctor if you have diabetes or risk factors for diabetes (for example, obesity, family history of diabetes), or if you have unexpected increases in thirst, urination, or hunger. If so, your blood sugar should be monitored. Increases in blood sugar levels (hyperglycemia), which in some cases can be serious and associated with coma or death, have been reported in patients taking Fanapt® and medicines like it.

Changes in cholesterol and triglycerides have been seen in patients taking Fanapt® and medicines like it. Check with your doctor while on treatment.

Some patients may gain weight while taking Fanapt®. Your doctor should check your weight regularly.

Tell your doctor about any medical conditions that you have including problems with your liver. Fanapt® is not recommended for patients with severe liver problems.

Tell your doctor if you have a history of or have a condition that may increase your risk for seizures before you begin taking Fanapt®.

Light-headedness or faintness caused by a sudden change in heart rate and blood pressure when rising quickly from a sitting or lying position (orthostatic hypotension) has been reported with Fanapt®. This condition is most common when you start therapy, when re-starting treatment, or when the dose of Fanapt® is increased. You should consult your doctor if you have or have had heart problems or conditions that lead to these sudden changes since Fanapt® should be used with caution in these patients.

Decreases in infection-fighting white blood cells (WBCs) have been reported in some patients taking antipsychotic agents. Patients with a preexisting history of low WBC count or who have experienced a low WBC count due to drug therapy should have their blood tested and monitored during the first few months of therapy. Some (including fatal) cases of agranulocytosis, a serious decrease in specific types of WBCs called neutrophils or granulocytes, have been reported in drugs like Fanapt®.

Fanapt® can increase the level of the hormone prolactin. Tell your doctor if you experience breast enlargement, breast pain, or breast discharge, abnormal menstrual cycles in females or impotence in males. If elevated levels of prolactin persist, this may lead to bone loss.

Medicines like Fanapt® can impact your body's ability to reduce your body temperature. You should avoid overheating and dehydration.

Fanapt® and medicines like it have been associated with swallowing problems (dysphagia). If you have or have had swallowing problems, you should tell your doctor.

As with many conditions that affect the way you think or feel, thoughts of suicide may occur. If you get these feelings, seek help immediately from your doctor, or local emergency room.

For males, in the rare event you have a painful or prolonged erection (priapism), lasting 4 or more hours, stop using Fanapt® and seek immediate medical attention.

Fanapt® and medicines like it can affect your judgment, thinking, or motor skills. You should not drive or operate hazardous machinery, including automobiles, until you know how Fanapt® affects you.

The most common side effects for Fanapt® versus placebo were dizziness, dry mouth, feeling unusually tired or sleepy, stuffy nose, feeling faint/light-headed when standing quickly, racing heartbeat, and weight gain. The average weight gain in clinical studies lasting 4-6 weeks was 5 lbs. If you experience any of these symptoms, talk with your doctor.

When taking Fanapt®, you should avoid drinking alcohol, and you should not breastfeed. You should notify your doctor if you become pregnant or intend to become pregnant while taking Fanapt®. Tell your doctor about all prescription and nonprescription medicines and supplements you are taking. Some medications may interact with Fanapt®.

To access the full Prescribing Information, including BOXED WARNING, visit www.Fanapt.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

To learn more, visit www.FANAPT.com

VANDA and FANAPT are registered trademarks of Vanda Pharmaceuticals Inc. in the United States and other countries.
FANAPT® is licensed by Vanda Pharmaceuticals Inc. from Titan Pharmaceuticals, Inc.

©2017 Vanda Pharmaceuticals Inc. All rights reserved. FAN0071V3 5/17